Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization-Reference-Cited by-同舟云学术

Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization

Published:2016-04-13 Issue:1 Volume:10 Page:228-237
ISSN:1933-0219
Container-title:Mucosal Immunology
language:en
Short-container-title:Mucosal Immunol

Author:

Fouda G G,Eudailey J,Kunz E L,Amos J D,Liebl B E,Himes J,Boakye-Agyeman F,Beck K,Michaels A J,Cohen-Wolkowiez M,Haynes B F,Reimann K A,Permar S R

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/mi201632.pdf

Reference46 articles.

1. UNAIDS 2014 Progress report on the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive.

2. Bork, K.A. et al. Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study. Am. J. Clin. Nutr. 100, 1559–1568 (2014).

3. Fowler, M.G. et al. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J. Acquir. Immune Defic. Syndr. 65, 366–374 (2014).

4. Kesho Bora Study Group de Vincenzi, I. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect. Dis. 11, 171–180 (2011).

5. Thomas, T.K. et al. Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding—the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med. 8, e1001015 (2011).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Human milk antibodies to global pathogens reveal geographic and interindividual variations in IgA and IgG;Journal of Clinical Investigation;2024-06-11

3. In vivo antiviral efficacy of LCTG-002, a pooled, purified human milk secretory IgA product, against SARS-CoV-2 in a murine model of COVID-19;Human Vaccines & Immunotherapeutics;2024-01-22

4. In Vivo Antiviral Efficacy of LCTG-002, a Pooled, Purified Human Milk Secretory IgA product, Against SARS-CoV-2 in a Murine Model of COVID-19;2023-08-28

5. The Secretory IgA Response in Human Milk Against the SARS-CoV-2 Spike Is Highly Durable and Neutralizing for At Least 1 Year of Lactation Postinfection;Breastfeeding Medicine;2023-08-01